Detalhe da pesquisa
1.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
N Engl J Med
; 389(21): 1961-1971, 2023 Nov 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37870920
2.
Malignancy, masculinities, and psychological distress: Comparisons made between men with testicular cancer and healthy controls.
Psychooncology
; 33(1): e6262, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38102869
3.
Self-perceptions of masculinities and testicular cancer: Qualitative explorations.
Psychooncology
; 33(3): e6333, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38520671
4.
Controversies in terminology associated with management of BCG-unresponsive NMIBC in Asia-Pacific.
Int J Urol
; 31(1): 32-38, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37795933
5.
Risk stratification and management of non-muscle-invasive bladder cancer: A physician survey in six Asia-Pacific territories.
Int J Urol
; 31(1): 64-71, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37800879
6.
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Br J Cancer
; 129(2): 309-317, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37237172
7.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36573926
8.
Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors.
Can J Urol
; 30(3): 11558-11561, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37344468
9.
Molecular classification of hormone-sensitive and castration-resistant prostate cancer, using nonnegative matrix factorization molecular subtyping of primary and metastatic specimens.
Prostate
; 82(9): 993-1002, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35435276
10.
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer.
BMC Med
; 20(1): 112, 2022 03 25.
Artigo
Inglês
| MEDLINE | ID: mdl-35331214
11.
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres.
BJU Int
; 130 Suppl 1: 5-16, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35355402
12.
Peritoneal carcinosis in male germ cell tumor patients: a registry study compiled by the German Testicular Cancer Study Group (GTCSG).
World J Urol
; 40(2): 355-361, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34993564
13.
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
World J Urol
; 40(1): 119-126, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34599350
14.
The impact of testicular cancer and its treatment on masculinity: A systematic review.
Psychooncology
; 31(9): 1459-1473, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35789023
15.
Genetics of testicular cancer: a review.
Curr Opin Urol
; 32(5): 481-487, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35855571
16.
Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
Intern Med J
; 52(8): 1339-1346, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33710759
17.
Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
Int J Cancer
; 149(2): 409-419, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33729581
18.
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer.
BJU Int
; 128 Suppl 1: 18-26, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34622543
19.
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
World J Urol
; 39(9): 3407-3414, 2021 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-33683412
20.
Demonstrating the feasibility of collecting secondary, de-identified data on Australian patients receiving treatment as part of a Medicine Access Programme.
Intern Med J
; 50(1): 99-104, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30816606